Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats

Journal of Hepatology

Volumn 64, Issue 4, 2016, Pages 834-842

  Cerini, Federica ^a   Vilaseca, Marina ^a,c,e   Lafoz, Erica ^a,e   García Irigoyen, Oihane ^b,c   García Calderó, Héctor ^a,c,e   Tripathi, Dinesh M ^a,e   Avila, Matias ^b,c   Reverter, Juan Carlos ^d,e   Bosch, Jaime ^a,c,e   Gracia Sancho, Jordi ^a,c,e   García Pagán, Juan Carlos ^a,c,e  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Hospital Sant Joan de Déu   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Anticoagulation; Cirrhosis; Hepatic stellate cells; Low molecular weight heparin; Portal hypertension

Indexed keywords

CARBON TETRACHLORIDE; DESMIN; ENOXAPARIN; NITRIC OXIDE; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEMODYNAMIC PARAMETERS; INTRAHEPATIC MICROTHROMBOSIS; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MEAN ARTERIAL PRESSURE; MICROTHROMBUS; NONHUMAN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; VASCULAR RESISTANCE; ANIMAL; DRUG EFFECTS; LIVER CIRRHOSIS, EXPERIMENTAL; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; ENOXAPARIN; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PORTAL PRESSURE; RATS; RATS, WISTAR; VASCULAR RESISTANCE;

EID: 84955507528     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.12.003     Document Type: Article

References (45)

1. J. Bosch, and J.C. Garcia-Pagan Complications of cirrhosis I. Portal hypertension J Hepatol 32 2000 141 156
2. J.C. Garcia-Pagan, J. Gracia-Sancho, and J. Bosch Functional aspects on the pathophysiology of portal hypertension in cirrhosis J Hepatol 57 2012 458 461
3. M. Pinzani, and P. Gentilini Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis Semin Liver Dis 19 1999 397 410
4. F. Tacke, T. Luedde, and C. Trautwein Inflammatory pathways in liver homeostasis and liver injury Clin Rev Allergy Immunol 36 2009 4 12
5. R.C. Chambers Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1 Biochem J 333 1998 121 127
6. R.C. Chambers Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1 J Biol Chem 275 2000 35584 35591
7. J.G. Duplantier A role for thrombin in liver fibrosis Gut 53 2004 1682 1687
8. Q.M. Anstee, M. Wright, R. Goldin, and M.R. Thursz Parenchymal extinction: coagulation and hepatic fibrogenesis Clin Liver Dis 13 2009 117 126
9. K. Borensztajn, J.H. von der Thusen, M.P. Peppelenbosch, and C.A. Spek The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm J Cell Mol Med 14 2010 143 153
10. F. Marra Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury Hepatology 27 1998 462 471
11. S. Fiorucci PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation Hepatology 39 2004 365 375
12. A. Rullier Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis Am J Physiol Gastrointest Liver Physiol 294 2008 G226 G235
13. M.D. Gaca, X. Zhou, and R.C. Benyon Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors J Hepatol 36 2002 362 369
14. K. Borensztajn, J. Stiekema, S. Nijmeijer, P.H. Reitsma, M.P. Peppelenbosch, and C.A. Spek Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation Am J Pathol 172 2008 309 320
15. V. Knight, J. Tchongue, D. Lourensz, P. Tipping, and W. Sievert Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells Hepatology 55 2012 879 887
16. I.R. Wanless, J.J. Liu, and J. Butany Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis) Hepatology 21 1995 1232 1237
17. I.R. Wanless, F. Wong, L.M. Blendis, P. Greig, E.J. Heathcote, and G. Levy Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension Hepatology 21 1995 1238 1247
18. V. Laux, E. Perzborn, S. Heitmeier, G. Von Degenfeld, E. Dittrich-Wengenroth, A. Buchmuller, and et al. Direct inhibitors of coagulation proteins - The end of the heparin and low-molecular-weight heparin era for anticoagulant therapy? Thromb Haemost 102 2009 892 899
19. O.M. Abdel-Salam, A.R. Baiuomy, A. Ameen, and N.S. Hassan A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat Pharmacol Res 51 2005 59 67
20. N. Assy, O. Hussein, A. Khalil, A. Luder, S. Szvalb, M. Paizi, and et al. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis Dig Dis Sci 52 2007 1187 1193
21. W. Abe, K. Ikejima, T. Lang, K. Okumura, N. Enomoto, T. Kitamura, and et al. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat J Hepatol 46 2007 286 294
22. E. Villa, C. Camma, M. Marietta, M. Luongo, R. Critelli, S. Colopi, and et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis Gastroenterology 143 2012 1253 1260
23. A. Tasatargil, C. Ogutman, I. Golbasi, E. Karasu, and S. Dalaklioglu Comparison of the vasodilatory effect of nadroparin, enoxaparin, dalteparin, and unfractioned heparin in human internal mammary artery J Cardiovasc Pharmacol 45 2005 550 554
24. S. Yague, A.V. Alvarez, A. Castilla, F.R. Gonzalez Pacheco, P. Llamas, and C. Caramelo Modulation of the effect of vascular endothelial growth factor on endothelial cells by heparin: critical role of nitric oxide-mediated mechanisms J Nephrol 18 2005 234 242
25. E.J. Paredes-Gamero, V.P. Medeiros, E.H. Farias, G.Z. Justo, E.S. Trindade, A.L. Andrade-Lopes, and et al. Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors Hypertension 56 2010 713 721
26. M. Di Pascoli, M. Divi, A. Rodriguez-Vilarrupla, E. Rosado, J. Gracia-Sancho, M. Vilaseca, and et al. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats J Hepatol 58 2013 904 910
27. S. Frizelle, J. Schwarz, S.A. Huber, and K. Leslie Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice Am J Pathol 141 1992 203 209
28. J.G. Abraldes, A. Rodriguez-Vilarrupla, M. Graupera, C. Zafra, H. Garcia-Caldero, J.C. Garcia-Pagan, and et al. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl(4) cirrhotic rats J Hepatol 15 2007 1040 1046
29. J. Gracia-Sancho, B. Lavina, A. Rodriguez-Vilarupla, H. Garcia-Caldero, M. Fernandez, J. Bosch, and et al. Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability Hepatology 47 2008 1248 1256
30. J. Gracia-Sancho, L. Russo, H. Garcia-Caldero, J.C. Garcia-Pagan, G. Garcia-Cardena, and J. Bosch Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver Gut 60 2011 517 524
31. O. Garcia-Irigoyen, S. Carotti, M.U. Latasa, I. Uriarte, M.G. Fernandez-Barrena, M. Elizalde, and et al. Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair Liver Int 34 2014 e257 e270
32. J.P. Luyendyk, G.H. Cantor, D. Kirchhofer, N. Mackman, B.L. Copple, and R. Wang Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice Am J Physiol Gastrointest Liver Physiol 296 2009 G840 G849
33. T. Sasaki, M. Kuzuya, X.W. Cheng, K. Nakamura, N. Tamaya-Mori, K. Maeda, and et al. A novel model of occlusive thrombus formation in mice Lab Invest 84 2004 1526 1532
34. M. Guillaume, A. Rodriguez-Vilarrupla, J. Gracia-Sancho, E. Rosado, A. Mancini, J. Bosch, and et al. Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats J Hepatol 58 2013 240 246
35. G. Marrone, R. Maeso-Díaz, G. Garcia-Cardena, J.C. Garcia-Pagan, J. Bosch, and J. Gracia-Sancho KLF2 exerts anti-fibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins Gut 64 2015 1434 1443
36. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
37. M. Wright, R. Goldin, S. Hellier, S. Knapp, A. Frodsham, B. Hennig, and et al. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection Gut 52 2003 1206 1210
38. A. Tripodi, M. Primignani, V. Chantarangkul, A. Dell'Era, M. Clerici, R. de Franchis, and et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis Gastroenterology 137 2009 2105 2111
39. T. Lisman, and F.W. Leebeek Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment Dig Surg 24 2007 250 258
40. M. Kume, T. Hayashi, H. Yuasa, H. Tanaka, J. Nishioka, M. Ido, and et al. Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats - A possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction J Hepatol 38 2003 9 17
41. Y.P. de Visser, F.J. Walther, H. Laghmani el, H. Boersma, A, van der Laarse, and G.T. Wagenaar Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury Respir Res 10 2009 30
42. B.P. Sullivan, K.M. Kassel, A. Jone, M.J. Flick, and J.P. Luyendyk Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury Am J Pathol 180 2012 2321 2329
43. D.A. Simonetto, H.Y. Yang, M. Yin, T.M. de Assuncao, J.H. Kwon, M. Hilscher, and et al. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces Hepatology 61 2015 648 659
44. L. Amitrano, M.A. Guardascione, A. Menchise, R. Martino, M. Scaglione, S. Giovine, and et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis J Clin Gastroenterol 44 2010 448 451
45. M.G. Delgado, S. Seijo, I. Yepes, L. Achecar, M.V. Catalina, A. Garcia-Criado, and et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis Clin Gastroenterol Hepatol 10 2012 776 783